Cantor Fitzgerald Starts Given Imaging (GIVN) at Buy;
Cantor Fitzgerald initiates coverage on Given Imaging (NASDAQ: GIVN) with a Buy. PT $23.00.
Cantor analyst said, "Given's consistently solid operating results in the face of weak patient volumes in the U.S. and continuing economic uncertainty in Europe are a testament to its strong product innovation and management, in our opinion. While there is plenty to like about the base business and balance sheet, we believe that Colon 2 remains the reason to own this stock. Even with the recent strength in shares, we would still be buyers here."
How come people are ignoring Chinese Co. that is selling over 80 mil.$ now-far more than Given Imaging in All countries excluding US.? This co.OMOM prices are much lower(at least 30% lower),quality much better.This co.was broadcast on TV in China.Showed their determination-Brazil and Spain are good examples.They are selling at half price in China.